z-logo
open-access-imgOpen Access
Risk of QTc prolongation with Chloroquine/Hyroxychloroquine and Azithromycin treatment for COVID‐19: Quantification and precautions for a busy clinician
Author(s) -
Mansuri Zeeshan,
Adnan Mahwish,
Motiwala Fatima,
Zafar Muhammad Khalid,
Jolly Taranjeet,
Jain Shailesh
Publication year - 2020
Publication title -
journal of arrhythmia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.463
H-Index - 21
eISSN - 1883-2148
pISSN - 1880-4276
DOI - 10.1002/joa3.12393
Subject(s) - azithromycin , medicine , chloroquine , covid-19 , prolongation , qt interval , hydroxychloroquine , virology , pharmacology , intensive care medicine , immunology , antibiotics , malaria , genetics , disease , infectious disease (medical specialty) , biology , outbreak

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom